Tags: Coronavirus | Vaccines | oxford | astrazeneca | variant | uk | strain

Oxford Says Oxford/AstraZeneca COVID-19 Vaccine Effective Against Strain

astrazeneca logo is shown on a building
(AP)

Friday, 05 February 2021 08:51 AM

Oxford University:

  • Oxford vaccine effective against major B.1.1.7 'Kent' coronavirus strain circulating in U.K.
  • Preprint of ongoing work to assess effectiveness of its vaccine shows vaccine has similar efficacy against B.1.1.7 'Kent' coronavirus strain.
  • Researchers who developed ChAdOx1 nCoV-19 vaccine have found that it remains effective against one of new variants of disease.
  • Data from trials of ChAdOx1 vaccine in U.K. indicate vaccine also protects against novel variant, B.1.1.7.
  • Between Oct. 1-Jan. 14, researchers used swabs taken from volunteers with symptomatic & asymptomatic infection enrolled in phase 2/3 study.
  • Vaccine researchers are already looking at ways to modify existing vaccines quickly and simply to protect against new variants.
  • Working with AstraZeneca to optimize pipeline required for a strain change should one become necessary.
  • Protection against symptomatic infection similar despite lower neutralizing antibody titres in vaccinated individuals against B.1.1.7 variant than 'Victoria' strain of virus.

© 2021 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
Companies
Oxford University: Oxford vaccine effective against major B.1.1.7 'Kent' coronavirus strain circulating in U.K. Preprint of ongoing work to assess effectiveness of its vaccine shows vaccine has similar efficacy against B.1.1.7 'Kent' coronavirus strain. Researchers who...
oxford, astrazeneca, variant, uk, strain, kent
144
2021-51-05
Friday, 05 February 2021 08:51 AM
Newsmax Media, Inc.
 
Newsmax TV Live

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved